CYMABAY THERAPEUTICS INC shareholders Q3 2023

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 194 filers reported holding CYMABAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.

CYMABAY THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CWM, LLC 26$00.00%
COMERICA BANK 1,353$20,1740.00%
Belvedere Trading LLC 2,051$30,5800.00%
Belvedere Trading LLC 3,100$46,2210.00%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 90,000$2,2500.00%
PRINCIPAL FINANCIAL GROUP INC 10,345$154,2440.00%
Cutler Group LLC / CA 200$20.00%
Hillsdale Investment Management Inc. 340$5,0690.00%
UBS Group AG 24,900$371,2590.00%
RAYMOND JAMES & ASSOCIATES 39,515$589,1690.00%
ENVESTNET ASSET MANAGEMENT INC 63,428$945,7110.00%
JANE STREET GROUP, LLC 58,648$874,4420.00%
J.P. Morgan Private Wealth Advisors LLC 10,627$158,4490.00%
Citadel Advisors 122,400$1,824,9840.00%
Citadel Advisors 113,307$1,689,4070.00%
Legal & General Group Plc 83,189$1,240,3490.00%
SIGNATUREFD, LLC 201$2,9970.00%
Cutler Group LLC / CA 3,600$10.00%
CANADA LIFE ASSURANCE Co 8,424$1260.00%
Daiwa Securities Group Inc. 341$50.00%
External links

This page lists CYMABAY THERAPEUTICS INC's shareholders in Q3 2023. To view CYMABAY THERAPEUTICS INC's shareholder history, click here.